CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-01 | Bunker Kevin D. Chief Operating Officer | Sale | −420 | $53.18 | $22K | 25,260 |
| 2021-07-01 | Epperly Melissa B, Chief Financial Officer | Sale | −700 | $50.10 | $35K | 259,457 |
| 2021-07-01 | Epperly Melissa B, Chief Financial Officer | Sale | −1,378 | $51.15 | $70K | 258,079 |
| 2021-07-01 | Epperly Melissa B, Chief Financial Officer | Sale | −805 | $52.01 | $42K | 257,274 |
| 2021-07-01 | Epperly Melissa B, Chief Financial Officer | Sale | −200 | $53.19 | $11K | 257,074 |
| 2021-07-01 | SUN ANTHONY Y President & CEO | Sale | −7,349 | $50.17 | $369K | 1,413,224 |
| 2021-07-01 | SUN ANTHONY Y President & CEO | Sale | −13,365 | $51.27 | $685K | 1,399,859 |
| 2021-07-01 | SUN ANTHONY Y President & CEO | Sale | −5,180 | $52.20 | $270K | 1,394,679 |
| 2021-07-01 | SUN ANTHONY Y President & CEO | Sale | −900 | $53.20 | $48K | 1,393,779 |
| 2021-06-04 | Johnson David Michael Director | Grant or award | +7,500 | 96,355 | ||
| 2021-06-04 | Johnson David Michael Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2021-06-04 | Blackwell Kimberly Director | Grant or award | +5,000 | 5,000 | ||
| 2021-06-04 | Blackwell Kimberly Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-04 | Johnson David Michael Director | Grant or award | +5,000 | 93,855 | ||
| 2021-06-04 | Johnson David Michael Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-06-01 | Gallagher Cam Director | Sale | −8,728 | $53.97 | $471K | 516,845 |
| 2021-06-01 | Gallagher Cam Director | Sale | −1,272 | $54.61 | $69K | 515,573 |
| 2021-06-01 | Bunker Kevin D. Chief Operating Officer | Sale | −7,571 | $54.00 | $409K | 34,529 |
| 2021-06-01 | Bunker Kevin D. Chief Operating Officer | Sale | −849 | $54.86 | $47K | 33,680 |
| 2021-06-01 | Epperly Melissa B, Chief Financial Officer | Sale | −2,883 | $53.99 | $156K | 260,357 |
Page 22 of 28 · 545 trades